AXSOME Trademark

Trademark Overview


On Wednesday, July 26, 2023, a trademark application was filed for AXSOME with the United States Patent and Trademark Office. The USPTO has given the AXSOME trademark a serial number of 98102362. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by Axsome Therapeutics, Inc.. The AXSOME trademark is filed in the Pharmaceutical Products category with the following description:

house mark for medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss
axsome

General Information


Serial Number98102362
Word MarkAXSOME
Filing DateWednesday, July 26, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and Serviceshouse mark for medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics, antifungals preparations, antivirals, and for treatment of cardiovascular, dermatological, respiratory, central nervous system, gastro-intestinal diseases, autoimmune, metabolic, endocrine, musculo-skeletal, genitourinary, tissue and organ, ocular, ophthalmological, immune system, pain, kidney, urological, and bone diseases and disorders and for the treatment of fibromyalgia, smoking cessation, narcolepsy, excessive daytime sleepiness, alzheimer's disease agitation, migraine, depression, diabetes, hypertension, skin disorders, allergies, asthma, obesity, and hair loss

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAxsome Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Party NameAxsome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Trademark Events


Event DateEvent Description
Saturday, July 29, 2023NEW APPLICATION ENTERED
Tuesday, August 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 14, 2024ASSIGNED TO EXAMINER
Thursday, March 21, 2024NON-FINAL ACTION WRITTEN
Thursday, March 21, 2024NON-FINAL ACTION E-MAILED
Thursday, March 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 4, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, April 4, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, April 4, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 4, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, April 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED